4-(3,5-Di-tert-butyl-4-oxocyclohexa-2,5-dien-1-ylidene)-5-methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one, 97%, 1g

(S)-(+)-Pyrrolidine-3-carboxylic acid hydrochloride, 97.0%, 5g

4-Chloro-2-formylphenylboronic acid, 98.0%, 100g

3,4-Dichloro-n-propylbenzene-1-sulfonamide, 95%, 250mg

(4-methoxyphenyl)(oxan-4-yl)methanamine hydrochloride, 98%, 250mg

Maltose, 95.0%, 100g

Methyl 2-((3S,4R)-4-aminopyrrolidin-3-yl)acetate bis(4-methylbenzenesulfonate), 95%, 100mg

2-Bromo-5-iodoanisole, 95.0%, 5g

(5-Chloro-2-fluoro-4-methoxyphenyl)methanol, 97%, 1g

1-((2S,3S)-2-(Benzyloxy)pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-1H-1,2,4-triazol-5(4H)-one, 95%, 5g

Diisopropilamina, min 99,5%, para síntesis, 2,5L, envase de vidrio

(E)-3-(quinolin-4-yl)acrylic acid, 98%, 100mg

4-Bromo-3-phenylpyridine, 95.0%, 1g